Literature DB >> 23715042

Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials.

Scott A Davis, Steven R Feldman.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23715042     DOI： 10.1001/jamadermatol.2013.2843

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

1.  Performance, Reliability, Usability, and Safety of the ID-Cap System for Ingestion Event Monitoring in Healthy Volunteers: A Pilot Study.

Authors:  Glen P Flores; Brian Peace; Tony C Carnes; Susan L Baumgartner; D Eric Buffkin; Neil R Euliano; Larry N Smith
Journal:  Innov Clin Neurosci       Date:  2016-10-01

2.  Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching.

Authors:  Anat Fisher; Greg Carney; Ken Bassett; Colin R Dormuth
Journal:  Drugs Aging       Date:  2017-03       Impact factor: 3.923

3.  Influence of high risk of obstructive sleep apnea on adherence to antihypertensive treatment in outpatients.

Authors:  Camila G Righi; Denis Martinez; Sandro C Gonçalves; Miguel Gus; Leila B Moreira; Sandra C Fuchs; Flavio D Fuchs
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-03-07       Impact factor: 3.738

4.  Adherence and long-term outcomes of growth hormone therapy with easypod™ in pediatric subjects: Spanish ECOS study.

Authors:  María Dolores Rodríguez Arnao; Amparo Rodríguez Sánchez; Ignacio Díez López; Joaquín Ramírez Fernández; Jose Antonio Bermúdez de la Vega; Diego Yeste Fernández; María Chueca Guindulain; Raquel Corripio Collado; Jacobo Pérez Sánchez; Ana Fernández González
Journal:  Endocr Connect       Date:  2019-09-01       Impact factor: 3.335

5.  A telehealth approach to improving clinical trial access for infants with tuberous sclerosis complex.

Authors:  Carly Hyde; Maria Pizzano; Nicole M McDonald; Charles A Nelson; Connie Kasari; Elizabeth A Thiele; Shafali S Jeste
Journal:  J Neurodev Disord       Date:  2020-01-22       Impact factor: 4.025
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.